SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

A pregnant patient shares her journey to overcome opiate addiction to hydrocodone by starting Suboxone.

Today's world of disruptive change is defined by two terms: innovation and speed.  The big idea is important, but equally so is the path that innovation...